WHO, Pfizer Reach COVAX Deal For 40m COVID-19 Vaccine Doses

The WHO and pharmaceuticals giant Pfizer on Friday announced a deal for up to 40 million initial doses of the Pfizer-BioNTech Covid-19 vaccine for … Continue reading WHO, Pfizer Reach COVAX Deal For 40m COVID-19 Vaccine Doses

By Solomon Elusoji

Updated January 22, 2021

LAS VEGAS, NEVADA – JANUARY 12: A vial of the Pfizer-BioNTech COVID-19 vaccine is displayed at UNLV on January 12, 2021 in Las Vegas, Nevada. UNLV officials established the vaccination center on campus yesterday and plan to open another one next week at College of Southern Nevada in Henderson, Nevada, to distribute about 1,000 doses a week at each location to the Nevada System of Higher Education (NSHE) schools. The first vaccinations are going to front-line health care staff, including members of the UNLV medical, dental and nursing schools, people who see patients and university police officers. After that, plans are to vaccinate employees who work on campus, remaining NSHE staff and students living in on-campus housing, followed by the remaining student body and possibly the public. Ethan Miller/Getty Images/AFP Ethan Miller / GETTY IMAGES NORTH AMERICA / Getty Images via AFP

LAS VEGAS, NEVADA – JANUARY 12: A vial of the Pfizer-BioNTech COVID-19 vaccine is displayed at UNLV on January 12, 2021 in Las Vegas, Nevada.
Ethan Miller / GETTY IMAGES NORTH AMERICA / Getty Images via AFP

The WHO and pharmaceuticals giant Pfizer on Friday announced a deal for up to 40 million initial doses of the Pfizer-BioNTech Covid-19 vaccine for poorer countries, through Covax global pool.

“I’m glad to announce that Covax has signed an agreement with Pfizer-BioNTech for up to 40 million doses of its Covid-19 vaccine,” World Health Organization director-general Tedros Adhanom Ghebreyesus told a press conference in Geneva.

More to follow….